These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 8836966)
1. Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin A. Andrada-Serpa MJ; Schor D; Araújo AQ; Rumjanek VM J Neurol Sci; 1996 Jul; 139(1):7-14. PubMed ID: 8836966 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259 [TBL] [Abstract][Full Text] [Related]
3. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276 [TBL] [Abstract][Full Text] [Related]
4. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786 [TBL] [Abstract][Full Text] [Related]
5. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. Cavrois M; Gessain A; Gout O; Wain-Hobson S; Wattel E J Infect Dis; 2000 Oct; 182(4):1044-50. PubMed ID: 10979898 [TBL] [Abstract][Full Text] [Related]
6. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. Azimi N; Jacobson S; Leist T; Waldmann TA J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011 [TBL] [Abstract][Full Text] [Related]
7. [Anti HTLV-I antibody titers in seropositive infected individuals]. Galeno H; Ramírez E; Mora J; Ojeda M; Cartier L Rev Med Chil; 1994 Sep; 122(9):1004-7. PubMed ID: 7597329 [TBL] [Abstract][Full Text] [Related]
8. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro. Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162 [TBL] [Abstract][Full Text] [Related]
9. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals. Gadelha SR; Junior Alcântara LC; Costa GC; Acosta AX; Rios D; Kashima S; Covas DT; Galvão-Castro B J Med Virol; 2008 Dec; 80(12):2141-6. PubMed ID: 19040291 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenetic significance of HTLV-I infection and immune surveillance in HAM]. Fujihara K Rinsho Shinkeigaku; 1999 Jan; 39(1):21-3. PubMed ID: 10377790 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen. Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528 [TBL] [Abstract][Full Text] [Related]
12. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients. Cartier L; Ramirez E Arch Virol; 2005 Apr; 150(4):743-53. PubMed ID: 15592888 [TBL] [Abstract][Full Text] [Related]
13. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926 [TBL] [Abstract][Full Text] [Related]
14. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Böhler T; Nolting J; Kamar N; Gurragchaa P; Reisener K; Glander P; Neumayer HH; Budde K; Klupp J Ther Drug Monit; 2007 Feb; 29(1):77-86. PubMed ID: 17304154 [TBL] [Abstract][Full Text] [Related]
15. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence. Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164 [TBL] [Abstract][Full Text] [Related]
16. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil. Nobre V; Guedes AC; Martins ML; Barbosa-Stancioli EF; Serufo JC; Proietti FA; Ribas JG; Ferreira CE; Lambertucci JR; Clin Infect Dis; 2006 Nov; 43(10):1257-63. PubMed ID: 17051489 [TBL] [Abstract][Full Text] [Related]
17. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids. Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222 [TBL] [Abstract][Full Text] [Related]
18. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696 [TBL] [Abstract][Full Text] [Related]
19. Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: a correlation with the survival rate. Adamik B; Zimecki M; Właszczyk A; Kübler A Arch Immunol Ther Exp (Warsz); 1997; 45(4):277-84. PubMed ID: 9523001 [TBL] [Abstract][Full Text] [Related]
20. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]